ACCELERATING INNOVATION IN NK CELL THERAPY Logo (WIPO, 01/23/2019)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark ACCELERATING INNOVATION IN NK CELL THERAPY was filed as Word mark on 01/23/2019 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1478321 |
| Countries | 
|
| Base trademark |
No. 88048416,
July 23, 2018
|
| Application date | January 23, 2019 |
| Expiration date | July 11, 2022 |
Trademark owner
Paasheuvelweg 25A
1105 BP Amsterdam
NL
1105 BP Amsterdam
NL
Trademark representatives
31 rue de Fleurus
F-75006 Paris
FR
goods and services
05
Pharmaceutical preparations for the treatment of immuno
oncological disorders, cancer, diabetes, respiratory, heart,
neurological and auto immune disorders; stem cells for
medical purposes; living cells for medical use; biological
preparations for the treatment of cancer; therapeutics
utilizing NC cells for use in the treatment of cancer,
autoimmune disease and infectious diseases; cell
preparations, cellular vaccines and cellular biologics for
the treatment of cancer and infectious diseases by
autologous cell-based immunotherapy
42
Scientific and technological services, namely, scientific
research, design, analysis and testing in the field of
cancer evolution and new cancer therapies using natural
killer cells; industrial research in the field of new
pharmaceutical products and new cancer therapies; medical
and veterinary research services in the nature of the
manipulation of cells within a laboratory or research
facility to enable natural killer cells to be used for
medical or therapeutic purposes; scientific research in the
development of new cancer therapies; scientific research in
human and animal cell therapy; scientific research into
preparations for manipulating and adapting human and animal
cells; consultancy relating to all the aforesaid services;
conducting research and clinical trials for others relating
to the use and the engineering of natural killer cells and
cancer treatment and therapy; medical and scientific
research in the field of cancer treatment and diagnosis;
data collection for others for research purposes, namely,
the collection, testing and research of patient molecular
and genomic data; collection and preservation of human and
animal DNA for research purposes
44
Medical testing for diagnostic or treatment purposes in the
field of cancer research; medical diagnostic testing,
monitoring and reporting services; medical evaluation of
immuno oncological disorders, cancer, diabetes, respiratory,
heart, neurological and auto immune disorders; medical
monitoring services; medical diagnostic, prognostic and
theranostic screening and testing services; collection and
preservation of DNA for medical purposes; consulting
services in the nature of providing medical information;
consulting services in the field of healthcare and cancer
diagnoses; providing a website featuring health and
healthcare information related to cancer, testing and
screening; genetic testing for medical purposes; providing
information in the field of cancer prevention, screening,
diagnosis and treatment for medical diagnostic and treatment
purposes; providing genetics assessments in the nature of
genetic counseling; genetic testing for medical diagnostic
purposes; genomic testing for medical diagnostic purposes;
Gene analysis and sequencing and DNA analysis and sequencing
for medical diagnostic purposes and veterinary diagnostics
purposes; gene analysis and sequencing and DNA analysis and
sequencing for use in cancer diagnosis and treatment;
providing health and healthcare information related to
cancer research, via a website
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| February 17, 2023 | 2023/10 Gaz | US | RAW: Total Ceasing Effect |
| January 27, 2022 | 2022/5 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| February 20, 2021 | 2021/9 Gaz | AU | Rejection |
| December 16, 2020 | 2021/4 Gaz | KR | Rejection |
| September 10, 2020 | 2020/37 Gaz | JP | Rejection |
| June 19, 2020 | 2020/27 Gaz | EM | Rejection |
| May 25, 2020 | 2020/22 Gaz | KR | Rejection |
| May 24, 2020 | 2020/22 Gaz | AU | Rejection |
| December 10, 2019 | 2019/50 Gaz | GB | Rejection |
| November 13, 2019 | 2019/46 Gaz | AU | Rejection |
| October 16, 2019 | 2019/43 Gaz | CN | Rejection |
| September 16, 2019 | 2019/41 Gaz | EM | Rejection |
| July 30, 2019 | 2019/31 Gaz | GB | Rejection |
| January 23, 2019 | 2019/28 Gaz | US | Registration |
ID: 141478321